BA
63
5
WM
65
-3
EA
57
-2
HCP
43
-2
AMT
37
-8
L
55
-3
MNST
47
-2
QCOM
51
-5
NWS
60
-2
ECL
59
-3
GD
41
2
FFIV
67
-3
TMO
56
-2
EXR
53
-2
HRL
53
2
JCI
47
-4
CI
40
-5
GOOGL
67
8
LNC
29
-4
CTAS
49
3
BA
63
5
WM
65
-3
EA
57
-2
HCP
43
-2
AMT
37
-8
L
55
-3
MNST
47
-2
QCOM
51
-5
NWS
60
-2
ECL
59
-3
GD
41
2
FFIV
67
-3
TMO
56
-2
EXR
53
-2
HRL
53
2
JCI
47
-4
CI
40
-5
GOOGL
67
8
LNC
29
-4
CTAS
49
3
Financhill
Back

Aligos Therapeutics Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
74

ALGS
Aligos Therapeutics

Last Price:
30.61
Seasonality Move:
10.65%

7 Day Trial

ALL ACCESS PASS

$ 7

A 10,000% Dividend?!?

Watch the short presentation by clicking here.

Aligos Therapeutics Price Quote

$30.61
-0.21 (11.07%)
(Updated: December 11, 2024 at 5:05 AM ET)

Aligos Therapeutics Key Stats

Buy
74
Aligos Therapeutics (ALGS) is a Buy
Day range:
$27.10 - $31.80
52-week range:
$6.76 - $31.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.99
P/B ratio:
2.21%
Volume:
541K
Avg. volume:
538.5K
1-year change:
112.55%
Market cap:
$110.6M
Revenue:
$15.5M
EPS:
$-17.11

How Much Does Aligos Therapeutics Make?

Is Aligos Therapeutics Growing As A Company?

  • What Is Aligos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.61%
  • What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aligos Therapeutics Stock Price Performance

What Is Aligos Therapeutics 52-Week High & Low?

Aligos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aligos Therapeutics?

Is Aligos Therapeutics Cash Flow Positive?

  • What Is ALGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85M
  • What Is Aligos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.2M
  • What Is Aligos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$38.3M

Aligos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ALGS return on invested capital is -118.75%
  • What Is Aligos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -68.4%
  • What Is ALGS Return On Equity?
    ROE is a measure of profitability and is -118.75%

Aligos Therapeutics Earnings Date & Stock Price

Aligos Therapeutics Competitors

Aligos Therapeutics Dividend Yield

Aligos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -131.7%
Revenue: -60.82% 280.7%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 103.33
Upside from Last Price: 235.28%

Major Shareholders

  • How many ALGS shares are owned by institutional investors?
    14.8M ALGS shares are owned by institutional investors
  • How many ALGS shares are owned by insiders?
    0 ALGS shares are owned by insiders